Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi
- PMID: 11751980
- DOI: 10.4049/jimmunol.168.1.348
Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi
Abstract
Borrelia burgdorferi lipoproteins activate inflammatory cells through Toll-like receptor 2 (TLR2), suggesting that TLR2 could play a pivotal role in the host response to B. burgdorferi. TLR2 does play a critical role in host defense, as infected TLR2(-/-) mice harbored up to 100-fold more spirochetes in tissues than did TLR2(+/+) littermates. Spirochetes persisted at extremely elevated levels in TLR2-deficient mice for at least 8 wk following infection. Infected TLR2(-/-) mice developed normal Borrelia-specific Ab responses, as measured by quantity of Borrelia-specific Ig isotypes, the kinetics of class switching to IgG, and the complexity of the Ags recognized. These findings indicate that the failure to control spirochete levels in tissues is not due to an impaired acquired immune response. While macrophages from TLR2(-/-) mice were not responsive to lipoproteins, they did respond to nonlipoprotein components of sonicated spirochetes. These TLR2-independent responses could play a role during the inflammatory response to B. burgdorferi, as infected TLR2(-/-) mice developed greater ankle swelling than wild-type littermates. Thus, while TLR2-dependent signaling pathways play a major role in the innate host defense to B. burgdorferi, both inflammatory responses and the development of the acquired humoral response can occur in the absence of TLR2.
Similar articles
-
Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice.Nat Med. 2002 Aug;8(8):878-84. doi: 10.1038/nm732. Epub 2002 Jul 1. Nat Med. 2002. PMID: 12091878 Clinical Trial.
-
MyD88 plays a unique role in host defense but not arthritis development in Lyme disease.J Immunol. 2004 Aug 1;173(3):2003-10. doi: 10.4049/jimmunol.173.3.2003. J Immunol. 2004. PMID: 15265935
-
The Lyme disease vaccine takes its toll.Vector Borne Zoonotic Dis. 2002 Winter;2(4):217-22. doi: 10.1089/153036602321653798. Vector Borne Zoonotic Dis. 2002. PMID: 12804162
-
Borrelia pathogenesis research in the post-genomic and post-vaccine era.Curr Opin Microbiol. 2000 Feb;3(1):86-92. doi: 10.1016/s1369-5274(99)00056-9. Curr Opin Microbiol. 2000. PMID: 10679423 Review.
-
Sepsis and evolution of the innate immune response.Crit Care Med. 2001 Jul;29(7 Suppl):S2-6; discussion S6-7. doi: 10.1097/00003246-200107001-00002. Crit Care Med. 2001. PMID: 11445725 Review.
Cited by
-
Minimal role of interleukin 6 and toll-like receptor 2 and 4 in murine models of immune-mediated bone marrow failure.PLoS One. 2021 Mar 12;16(3):e0248343. doi: 10.1371/journal.pone.0248343. eCollection 2021. PLoS One. 2021. PMID: 33711076 Free PMC article.
-
Protective niche for Borrelia burgdorferi to evade humoral immunity.Am J Pathol. 2004 Sep;165(3):977-85. doi: 10.1016/S0002-9440(10)63359-7. Am J Pathol. 2004. PMID: 15331421 Free PMC article.
-
Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes.Infect Immun. 2008 Jan;76(1):56-70. doi: 10.1128/IAI.01039-07. Epub 2007 Oct 15. Infect Immun. 2008. PMID: 17938216 Free PMC article.
-
TLR2 expression in relation to IL-6 and IL-1beta and their natural regulators production by PMN and PBMC in patients with Lyme disease.Mediators Inflamm. 2006;2006(1):32071. doi: 10.1155/MI/2006/32071. Mediators Inflamm. 2006. PMID: 16864901 Free PMC article.
-
Effects of vlsE complementation on the infectivity of Borrelia burgdorferi lacking the linear plasmid lp28-1.Infect Immun. 2004 Nov;72(11):6577-85. doi: 10.1128/IAI.72.11.6577-6585.2004. Infect Immun. 2004. PMID: 15501789 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases